TickerFacts.

Ensysce Biosciences, Inc. (ENSC): Shares Outstanding

Annual figures by period end, from SEC filings.

Stock splits: 1-for-20, first reflected in a filing dated 2022-11-14; 1-for-15, first reflected in a filing dated 2025-03-10. Figures are as filed: per-share figures and share counts last reported before a split are on the old share basis, so changes and growth rates across a split are not shown. Splits are read from the filings' own restatements, so a share conversion in a merger or reorganization shows up the same way.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the year ended 2019-12-31 (for example after a spin-off or a discontinued operation), while the year before it was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

4.57M
As of 2025-12-31
16.23M
As of 2026-06-30
15.77M2017-12-31: 6.73M2018-12-31: 6.04M2019-12-31: 7.07M2020-12-31: 15.77M2021-12-31: 1.23M2022-12-31: 534.5K2023-12-31: 209.7K2024-12-31: 1.36M2025-12-31: 4.57M4.57M
2017-12-31 Shares Outstanding (shares) 2025-12-31

Paler bars were last filed before a stock split, on the old share basis.

Period endedShares OutstandingChange YoYSource filing
2025-12-314.57M+237.4%2026-03-30, Balance as of period end
2024-12-311.36M+546.4%2026-03-30, Balance as of period end
2023-12-31209.7Kn/c2025-03-10, Balance as of period end
2022-12-31534.5K-56.6%2024-03-15, Balance as of period end
2021-12-311.23Mn/c2023-03-30, Balance as of period end
2020-12-3115.77M+123.1%2022-03-31, Balance as of period end
2019-12-317.07Mn/c2021-06-08, Balance as of period end
2018-12-316.04M-10.3%2020-03-10, Balance as of period end
2017-12-316.73Mn/a2019-03-12, Balance as of period end